Erratum: Optimization of pyrrolamides as mycobacterial GyrB ATPase inhibitors: Structure-activity relationship and in vivo efficacy in a mouse model of tuberculosis (Antimicrobial Agents and Chemotherapy (2014) 58:1 (61-70))

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4993-4994

  Hameed, Shahul P ^a   Solapure, Suresh ^a   Mukherjee, Kakoli ^a   Nandi, Vrinda ^a   Waterson, David ^a   Shandil, Radha ^a   Balganesh, Meenakshi ^a   Sambandamurthy, Vasan K ^a   Raichurkar, Anand Kumar ^a   Deshpande, Abhijeet ^a   Ghosh, Anirban ^a   Awasthy, Disha ^a   Shanbhag, Gajanan ^a   Sheikh, Gulebahar ^a   McMiken, Helen ^a   Puttur, Jayashree ^a   Reddy, Jitendar ^a   Werngren, Jim ^b   Read, Jon ^a   Kumar, Mahesh ^a   Manjunatha, R ^a   Chinnapattu, Murugan ^a   Madhavapeddi, Prashanti ^a   Manjrekar, Praveena ^a   Basu, Reetobrata ^a   Gaonkar, Sheshagiri ^a   Sharma, Sreevalli ^a   Hoffner, Sven ^b   Humnabadkar, Vaishali ^a   Subbulakshmi, Venkita ^a   Panduga, Vijender ^a   more..

^a ASTRAZENECA   (United Kingdom)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905365227     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03463-14     Document Type: Erratum

References (0)